Neonatal Fc receptor promotes immune complex-mediated glomerular disease

Journal of the American Society of Nephrology

Volumn 25, Issue 5, 2014, Pages 918-925

  Olaru, Florina ^a   Luo, Wentian ^a   Suleiman, Hani ^b   St John, Patricia L ^c   Ge, Linna ^a   Mezo, Adam R ^d,f   Shaw, Andrey S ^b   Abrahamson, Dale R ^c   Miner, Jeffrey H ^b   Borza, Dorin Bogdan ^a,e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d BIOGEN   (United States)

^e MEHARRY MEDICAL COLLEGE   (United States)

^f ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA3 CHAIN OF TYPE IV COLLAGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5B; CREATININE; FC RECEPTOR; GELATINASE A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG; AUTOANTIGEN; COLLAGEN TYPE 4; FC RECEPTOR, NEONATAL; HLA ANTIGEN CLASS 1; TYPE IV COLLAGEN ALPHA3 CHAIN;

ACTIVE IMMUNIZATION; ALBUMINURIA; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; DEGRADATION; FETUS; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN CELL; HYPOALBUMINEMIA; IMMUNIZATION; KIDNEY DISEASE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MOTHER; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; ANIMAL; C57BL MOUSE; GLOMERULONEPHRITIS; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ALBUMINURIA; ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIGENS; COLLAGEN TYPE IV; GLOMERULONEPHRITIS; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, FC;

EID: 84906554621     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013050498     Document Type: Article

References (36)

1. Roopenian DC, Akilesh S: FcRn: The neonatal Fc receptor comes of age. Nat Rev Immunol 7: 715-725, 2007
2. Akilesh S, Petkova S, Sproule TJ, Shaffer DJ, Christianson GJ, Roopenian D: The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J Clin Invest 113: 1328-1333, 2004
3. Li N, Zhao M, Hilario-Vargas J, Prisayanh P, Warren S, Diaz LA, Roopenian DC, Liu Z: Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. J Clin Invest 115: 3440-3450, 2005
4. Sesarman A, Sitaru AG, Olaru F, Zillikens D, Sitaru C: Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita. J Mol Med (Berl) 86: 951-959, 2008
5. Haymann JP, Levraud JP, Bouet S, Kappes V, Hagège J, Nguyen G, Xu Y, Rondeau E, Sraer JD: Characterization and localization of the neonatal Fc receptor in adult human kidney. J Am Soc Nephrol 11: 632-639, 2000
6. Sarav M,Wang Y, Hack BK, Chang A, Jensen M, Bao L, Quigg RJ: Renal FcRn reclaims albumin but facilitates elimination of IgG.J Am Soc Nephrol 20: 1941-1952, 2009
7. Kobayashi N, Suzuki Y, Tsuge T, Okumura K, Ra C, Tomino Y: FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells. Am J Physiol Renal Physiol 282: F358-F365, 2002
8. Akilesh S, Huber TB, Wu H, Wang G, Hartleben B, Kopp JB, Miner JH, Roopenian DC, Unanue ER, Shaw AS: Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci U S A 105: 967-972, 2008
9. Gan H, Feng S, Wu H, Sun Y, Hu R, Zhao Z, Zhang Z: Neonatal Fc receptor stimulation induces ubiquitin c-terminal hydrolase-1 overexpression in podocytes through activation of p38 mitogen-activated protein kinase. Hum Pathol 43: 1482-1490, 2012
10. Hopfer H, Maron R, Butzmann U, Helmchen U, Weiner HL, Kalluri R: The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease inmice. FASEB J 17: 860-868, 2003
11. Chaudhury C, Mehnaz S, Robinson JM, Hayton WL, Pearl DK, Roopenian DC, Anderson CL: The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 197: 315-322, 2003
12. Koltun M, Nikolovski J, Strong K, Nikolic- Paterson D, Comper WD: Mechanism of hypoalbuminemia in rodents. Am J Physiol Heart Circ Physiol 288: H1604-H1610, 2005
13. Stein C, Kling L, Proetzel G, Roopenian DC, de Angelis MH, Wolf E, Rathkolb B: Clinical chemistry of human FcRn transgenic mice. Mamm Genome 23: 259-269, 2012
14. Hopfer H, Holzer J, Hünemörder S, Paust HJ, Sachs M, Meyer-Schwesinger C, Turner JE, Panzer U, Mittrücker HW: Characterization of the renal CD4+ T-cell response in experimental autoimmune glomerulonephritis. Kidney Int 82: 60-71, 2012
15. Zhang JJ,Malekpour M, LuoW,Ge L,Olaru F, Wang XP, Bah M, Sado Y, Heidet L, Kleinau S, Fogo AB, Borza DB: Murine membranous nephropathy: Immunization with α3(IV) collagen fragment induces subepithelial immune complexes and FcgR-independent nephrotic syndrome. J Immunol 188: 3268-3277, 2012
16. DebiecH,Guigonis V,Mougenot B,Decobert F, Haymann JP, Bensman A, Deschênes G, Ronco PM: Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies.N Engl J Med 346: 2053-2060, 2002
17. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
18. Debiec H, Lefeu F, Kemper MJ, Niaudet P, Deschênes G, Remuzzi G, Ulinski T, Ronco P: Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 364: 2101-2110, 2011
19. Borza DB, Zhang JJ, Beck LH Jr, Meyer-Schwesinger C, Luo W: Mouse models of membranous nephropathy: The road less travelled by. Am J Clin Exp Immunol 2: 135-145, 2013
20. Borza CM, Borza DB, Pedchenko V, Saleem MA, Mathieson PW, Sado Y, Hudson HM, Pozzi A, Saus J, Abrahamson DR, Zent R, Hudson BG:Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network. J Am Soc Nephrol 19: 677-684, 2008
21. Jia XY, Hu SY, Chen JL, Qu Z, Liu G, Cui Z, Zhao MH: The clinical and immunological features of patients with combined antiglomerular basement membrane disease and membranous nephropathy [published online ahead of print September 18, 2013]. Kidney Int doi:10.1038/ki.2013.364
22. Cybulsky AV, Rennke HG, Feintzeig ID, Salant DJ: Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy. J Clin Invest 77: 1096-1107, 1986
23. Cunningham PN, Quigg RJ: Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol 16: 1214-1222, 2005
24. Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG,Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ: Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 22: 1543-1550, 2011
25. Bleeker WK, Teeling JL, Hack CE: Accelerated autoantibody clearance by intravenous immunoglobulin therapy: Studies in experimental models to determine the magnitude and time course of the effect. Blood 98: 3136-3142, 2001
26. Nortier JL, Debiec H, Tournay Y, Mougenot B, Nöel JC, Deschodt-Lanckman MM, Janssen F, Ronco P: Neonatal disease in neutral endopeptidase alloimmunization: Lessons for immunological monitoring. Pediatr Nephrol 21: 1399-1405, 2006
27. Liu L, Garcia AM, Santoro H, Zhang Y, McDonnell K, Dumont J, Bitonti A: Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade. J Immunol 178: 5390-5398, 2007
28. Patel DA, Puig-Canto A, Challa DK, Perez Montoyo H, Ober RJ, Ward ES: Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model. J Immunol 187: 1015-1022, 2011
29. Mezo AR, Sridhar V, Badger J, Sakorafas P, Nienaber V: X-ray crystal structures of monomeric and dimeric peptide inhibitors in complex with the human neonatal Fc receptor, FcRn. J Biol Chem 285: 27694-27701, 2010
30. Mezo AR, McDonnell KA, Hehir CA, Low SC, Palombella VJ, Stattel JM, Kamphaus GD, Fraley C, Zhang Y, Dumont JA, Bitonti AJ: Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn. Proc Natl Acad Sci U S A 105: 2337-2342, 2008
31. Luo W, Wang XP, Kashtan CE, Borza DB: Alport alloantibodies but not Goodpasture autoantibodies induce murine glomerulonephritis: Protection by quinary crosslinks locking cryptic α3(IV) collagen autoepitopes in vivo. J Immunol 185: 3520-3528, 2010
32. Kang JS, Colon S, Hellmark T, Sado Y, Hudson BG, Borza DB: Identification of noncollagenous sites encoding specific interactions and quaternary assembly of alpha 3 alpha 4 alpha 5(IV) collagen: Implications for Alport gene therapy. J Biol Chem 283: 35070-35077, 2008
33. Olaru F, Wang XP, Luo W, Ge L, Miner JH, Kleinau S, Geiger XJ, Wasiluk A, Heidet L, Kitching AR, Borza DB: Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers. J Immunol 190: 1424-1432, 2013
34. Harvey SJ, Jarad G, Cunningham J, Rops AL, van der Vlag J, Berden JH, Moeller MJ, Holzman LB, Burgess RW, Miner JH: Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am J Pathol 171: 139-152, 2007
35. Dani A, Huang B, Bergan J, Dulac C, Zhuang X: Superresolution imaging of chemical synapses in the brain. Neuron 68: 843-856, 2010
36. Suleiman H, Zhang L, Roth R, Heuser JE, Miner JH, Shaw AS, Dani A: Nanoscale protein architecture of the kidney glomerular basement membrane. Elife 2: e01149, 2013